Schedule 13G ownership disclosure

ANIKA THERAPEUTICS INC

Common Stock, Par Value $0.01 Per Share · CUSIP: 035255108

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Trigran Investments, Inc.

    Shares: 1,621,215.00 · Class: 11.2%

  • Douglas T. Granat

    Shares: 1,621,215.00 · Class: 11.2%

  • Lawrence A. Oberman

    Shares: 1,621,215.00 · Class: 11.2%

  • Steven G. Simon

    Shares: 1,621,215.00 · Class: 11.2%

  • Bradley F. Simon

    Shares: 1,621,215.00 · Class: 11.2%

  • Steven R. Monieson

    Shares: 1,621,215.00 · Class: 11.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-108057
Form type
SCHEDULE 13G/A
Filer
Anika Therapeutics, Inc.
CIK
CIK 898437
Filed
Nov 07, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub